Published in TB and Outbreaks Week, May 22nd, 1995
Recent World Health Organization (WHO) recommendations emphasize the importance of linking drug-resistance information with clinical information to distinguish between initial and acquired resistance and between HIV-positive and HIV-negative patients.
The WHO report emphasized that acquired resistance should be measured in those known to have drug-sensitive bacilli at the start of treatment. The distinction is rarely made between acquired resistance in those known to have...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.